Cambridge Investment Research Advisors, Inc.
Position in GH — Guardant Health, Inc.
CIK 1419186
FAIRFIELD, IA
Position in GH
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$1,354,620
+$332,731 QoQ
Shares Held
9,029
-18.4% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#289
of 594 holders
Holding Since
Mar 2020
24 quarters on record
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Cambridge Investment Research Advisors, Inc. holds $56,202,312 across 19 Diagnostics & Research names. GH ranks #11 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
45,487 | $22,805,362 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
40,470 | $7,819,613 | |
| 3 | DHR |
Danaher Corp /De/
|
29,086 | $5,540,301 | |
| 4 | DGX |
Quest Diagnostics Inc
|
15,492 | $3,283,529 | |
| 5 | LH |
Labcorp Holdings Inc.
|
11,187 | $3,132,360 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
4,300 | $2,263,692 | |
| 7 | MEDP |
Medpace Holdings, Inc.
|
3,996 | $2,116,241 | |
| 8 | A |
Agilent Technologies, Inc.
|
11,896 | $1,580,145 |
All Filings in GH
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,354,620 | 9,029 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $1,021,889 | 11,063 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $1,107,708 | 10,845 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $686,092 | 10,981 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $636,917 | 12,239 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $534,800 | 12,554 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $507,038 | 16,597 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $225,454 | 9,828 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $282,648 | 9,787 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $546,261 | 26,479 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $671,867 | 24,838 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $761,273 | 25,684 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $507,858 | 14,186 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $341,731 | 14,579 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $220,728 | 8,115 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $325,187 | 6,041 | Shares | Sole | 2022-10-17 | |
| 2021-12-31 | $286,057 | 2,860 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $609,298 | 4,874 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $588,412 | 4,738 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,268,826 | 8,312 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $2,068,910 | 16,053 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $940,516 | 8,414 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $461,954 | 5,694 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $345,842 | 4,969 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||